Tower Research Capital LLC (Trc) Phio Pharmaceuticals Corp. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.33 - $63.51 $80 - $15,559	-245 Reduced 4.48%	5,220 $2,000
Q3 2022 Nov 10, 2022	SELL	$0.62 - $66.43 $1,685 - $180,556	-2,718 Reduced 33.22%	5,465 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.64 - $2.35 $5,237 - $19,230	8,183 New	8,183 $6,000
Q3 2021 Nov 15, 2021	SELL	$1.62 - $2.28 $1,108 - $1,559	-684 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.8 $1,279 - $1,915	684 New	684 $2,000
Q4 2020 Feb 16, 2021	SELL	$2.01 - $3.32 $1,167 - $1,928	-581 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.95 - $2.94 $1,132 - $1,708	581 New	581 $1,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $30.2M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.